{"id":332308,"date":"2026-02-11T20:33:22","date_gmt":"2026-02-11T20:33:22","guid":{"rendered":"https:\/\/www.europesays.com\/ie\/332308\/"},"modified":"2026-02-11T20:33:22","modified_gmt":"2026-02-11T20:33:22","slug":"nafdac-speaks-on-amoxicillin-ban-in-nigeria","status":"publish","type":"post","link":"https:\/\/www.europesays.com\/ie\/332308\/","title":{"rendered":"NAFDAC speaks on amoxicillin ban in Nigeria"},"content":{"rendered":"<p>The National Agency for Food and Drug Administration and Control, NAFDAC, has dismissed claims circulating about a purported secret ban on amoxicillin.<\/p>\n<p>In a statement by NAFDAC Director-General Prof. Moji Shola Adeyeye, she said that the agency has neither secretly nor openly planned a ban on amoxicillin.<\/p>\n<p>This was in response to a viral social media post claiming that NAFDAC had banned the antibiotic.<\/p>\n<p>Reacting, NAFDAC described the claim as false and devoid of any factual basis.<\/p>\n<p>\u201cNAFDAC has not banned amoxicillin in Nigeria, either secretly or openly,\u201d the regulatory agency said in a statement on Monday.<\/p>\n<p>It clarified that the agency publicly notifies Nigerians of any regulatory actions through official channels.<\/p>\n<p>\u201cIn recent months, NAFDAC issued targeted safety alerts on certain brands and batches of amoxicillin. In August 2025, Public Alert No. 24\/2025 announced the recall of Amoxivue (Amoxicillin) 500 mg capsules due to low Active Pharmaceutical Ingredient (API) content. In October 2025, Public Alert No. 34\/2025 addressed substandard batches of Astamocil and Astamentin suspensions, while Public Alert No. 35\/2025 notified the public of substandard batches of Annmox and Jawamox suspensions. These actions were specific to identified products and do not constitute a ban on amoxicillin,\u201d NAFDAC added.<\/p>\n","protected":false},"excerpt":{"rendered":"The National Agency for Food and Drug Administration and Control, NAFDAC, has dismissed claims circulating about a purported&hellip;\n","protected":false},"author":2,"featured_media":332309,"comment_status":"","ping_status":"","sticky":false,"template":"","format":"standard","meta":{"footnotes":"","_share_on_mastodon":"0"},"categories":[274],"tags":[157629,18,135,19,17,462,20124],"class_list":["post-332308","post","type-post","status-publish","format-standard","has-post-thumbnail","category-medication","tag-amoxicillin","tag-eire","tag-health","tag-ie","tag-ireland","tag-medication","tag-nafdac"],"share_on_mastodon":{"url":"https:\/\/pubeurope.com\/@ie\/116053908045301173","error":""},"_links":{"self":[{"href":"https:\/\/www.europesays.com\/ie\/wp-json\/wp\/v2\/posts\/332308","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.europesays.com\/ie\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.europesays.com\/ie\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/ie\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/ie\/wp-json\/wp\/v2\/comments?post=332308"}],"version-history":[{"count":0,"href":"https:\/\/www.europesays.com\/ie\/wp-json\/wp\/v2\/posts\/332308\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/ie\/wp-json\/wp\/v2\/media\/332309"}],"wp:attachment":[{"href":"https:\/\/www.europesays.com\/ie\/wp-json\/wp\/v2\/media?parent=332308"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.europesays.com\/ie\/wp-json\/wp\/v2\/categories?post=332308"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.europesays.com\/ie\/wp-json\/wp\/v2\/tags?post=332308"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}